The North American Spine Society released revised coverage recommendations for recombinant human bone morphogenetic protein BMP-2, adding select off-label indications now supported by clinical data.
The UK's nuclear revival is creating new investment opportunities across engineering, infrastructure, manufacturing and specialist services. Discover where private equity can add value.